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SELECTION OF TITANIUM SPECIFIC POLYPEPTIDES BY PHAGE 
DISPLAY TECHNIQUE 
SUMMARY 
In nature, nearly all of the organisms utilize organic-inorganic hybrid systems. Either 
these systems play structural and/or defensive roles, or function in intercellular 
interactions between cells. Proteins are the major molecules in formation of this type 
of hybrid systems. Proteins are, in fact the major building blocks of all organisms. 
Polypeptides are used in biotechnologic and nano-biotechnologic areas due to their 
excellent functionality in complexes with inorganic materials. 
Phage display technique is one of the combinatorial biology based selection 
techniques used in selection of inorganic binding peptides. Recent years, there is a 
great trend to study on selecting inorganic binding polypeptides by phage display 
technology. Some noble metals, metal oxides and semiconductors could be given as 
examples to these studies preformed recently. Inorganic specific polypeptides can be 
used in nanotechnological and bionanotechnological applications as molecular 
linkers and take role in inorganic biomineralization.  
In the current work, titanium specific polypeptides were selected via using phage 
display technique. The rationale for selecting titanium as an inorganic subtrate may 
be explained by its biocompatibility and popularity in medical implants, especially 
the dental implants. 
C7C phage library was used to select titanium specific polypeptides. Before 
screening, material characterization studies were carried out in order to get 
information about particle size, particle surface and morphology. After 3 rounds of 
screening 51 sequences were randomly selected to study the binding affinities and 
specificities. 
At the end of the  screening procedure amino acid distribution of selected sequences 
and observed amino acid frequencies in library were compared, after amino acids 
frequency analyses, fluorescence microscopy experiments were carried out in order 
to understand the binding affinity of selected polypeptides to titanium powder. After 
fluorescence microscopy studies, polypeptides were grouped as strong, moderate and 
weak binding polypeptides by their affinities. Selection of strong polypeptides was 
not considered sufficient to assure which polypeptide was “specific” to titanium 
therefore cross specificity experiments were performed with platinum, silver and 
silica by examination on fluorescence microscopy. 
 xi
TİTANYUMA ÖZGÜN OLAN POLİPEPTİTLERİN FAJ GÖSTERİM 
YÖNTEMİYLE SEÇİMİ 
ÖZET 
Doğadaki hemen hemen tüm organizmalar organik-inorganik hibrid sistemlerini 
kullanırlar. Bu sistemler yapısal ve/veya koruyucu amaçlı olmakla beraber aynı 
zamanda hücreler arası etkileşimde de görev alırlar. Bu tip organik-inorganik 
hibritlerin oluşmasında başlıca rolü proteinler oynamaktadır. Proteinler 
organizmaların en önemli yapıtaşlarındandır. Bu mükemmel işlevsellikleri nedeniyle 
inorganik malzemelere özgün olan polipeptidler biyoteknolojide ve 
nanobiyoteknolojide kullanılmaya çalışılmaktadır. 
Faj gösterim tekniği çeşitli inorganik malzeme yüzeylerine özgün olarak bağlanan 
polipeptitlerin seçiliminde kullanılan kombinatoryal biyoloji tabanlı bir yöntemdir. 
Son zamanlarda genetik mühendisliğinin büyük yol katetmesi sonucu inorganik 
yüzeylere bağlanan polipeptitler üzerine yapılan çalışmalar hızla artmaktadır. Bu 
malzemelere soy metaller, bazı metal oksitler ve yarı iletken malzemeler örnek 
verilebilir. İnorganiklere özgün olan polipeptitler moleküler bağlayıcı veya inorganik 
sentezi gibi nano ve bionanoteknolojik alanlarda kullanılabilir. 
Bu çalışmada toz titanyuma özgün polipeptitler faj gösterim yöntemiyle seçilmiştir. 
Titanyumun inorganik malzeme olarak seçilmesinin sebebi biyouyumluluğu yüksek 
bir malzeme olması ve tıp alanında özellikle diş implantlarında sıklıkla 
kullanılmasıdır. 
Titanyuma özgün polipeptitlerin seçimi C7C faj gösterim kütüphanesinden 
yapılmıştır. Faj gösterim protokolü uygulanmadan önce malzeme karakterizasyonu 
yapılıp, yüzey alanı, parçacık büyüklüğü ve yüzey morfolojisi hakkında bilgi 
edinilmiştir. Deney seti süresince 3 döngü yapılmıştır. Bu döngüler sonucunda 
rastgele 51 dizi seçilip titanyuma bağlanma eğilimi ve özgünlüğü incelenmiştir. 
Deney setinin sonunda, tanımlanan polipeptit dizilerinin amino asit oranları 
hesaplanarak faj kütüphanesindeki amino asit oranlarıyla karşılaştırılmıştır. Daha 
sonra orantısal analizleri yapılan polipeptit dizilerinin titanyuma bağlanma 
eğilimlerini araştırmak için floresan mikroskobu çalışması yapılmıştır. Seçilen 
polipeptitlerin titanyumun yüzeyine bağlanma eğilimleri incelenip, güçlü, orta ve 
zayıf bağlanan olarak 3 kategoriye ayrılmıştır. Güçlü bağlanan polipeptitler 
titanyuma olan özgünlüğünü anlamak için platin, gümüş ve silika ile florasan 
mikroskobu çalışmaları yapılmıştır. 
 xii
 1. INTRODUCTION 
1.1 Inorganic material binding polypeptides in biological organisms, and their 
significance. 
Proteins are the major building blocks in biological organisms. Due to their unique 
and specific interactions with other macromolecules, they can build up cell structure 
and take major role in functional cell properties like tissue formation and catalyzing 
enzymatic reactions [1]. Proteins participate in forming complex nano structures in 
soft [2] and hard [3] tissues. Muscle, skin, tendon, membrane, silk of spider are the 
main soft tissues that contain only proteinaceous phase. In hard tissues such as bones, 
dental tissues (i.e., dentine and enamel), spicules, spines, shells, skeletal units of 
single-celled organisms (e.g., radiolarian) or plants, bacterial thin film, and 
nanoparticles [3,4] contain both at least one proteinaceous and inorganic phase. Hard 
and soft tissues are synthesized in organisms at ambient conditions and aqueous 
environment by genetic control [4,5,6]. Fig. 1.1 shows examples of organic-inorganic 
hybrid material formations in some organisms [7]. The inorganic material, on which 
the proteinaceous phase is bound, commonly includes magnetite (Fe3O4) particles in 
magnetotactic bacteria or teeth of chiton [8]; silica (SiO2) as skeletons of radiolarian 
[3] or tiny light-gathering lenses and optical wave guides in sponges [9]; 
hydroxyapatite (Ca2C(OH)3) in bones [10] and dental tissues of mammals [11] 
calcium carbonate (CaCO3) in the shells of mollusks [12]. All these hybrid systems 
are naturally produced in organisms by using protein – inorganic interactions. These 
systems play important roles in evolution such as supporting elements, defencing 
units, some optical and mechanical properties that help organism to adapt to its 
habitat. All these tissues are produced in organisms mainly by using proteins under 
genetic control. In addition to enzymatic reactions in the synthesis of inorganic 
phases, proteins collect and transport raw materials and consistently and uniformly 
self- and co-assemble subunits into short- and long-range ordered nuclei and 
substrates [9-11].  Whether controlling or participating in tissue formation and 
regeneration, or being an integral part of the tissue in its biological functions and 
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 physical performance, proteins are an indispensable part of biological structures and 
systems. Therefore, proteins are the workhorses that control the fabrication of 
biological structures by orchestrating the assembly of materials in two and three 
dimensions [7]. 
 
 
Fig. 1.1 Examples of biologically synthesized organic-inorganic hybrid materials: (a) 
Single-crystalline, single-domained magnetic magnetite nanoparticles (Fe3O4) 
formed by a magnetotactic bacterium (Aquaspirillum magnetotacticum) (inset: 
higher magnification image of the magnetite nanoparticles revealing cubo-octahedral 
particle shape). (b) S-layer bacterium, Synechococcus strain GL24, has a 
nanostructurally ordered thin film calcite on its outer layer serving as a protective 
coating. (c) Hard, wear-resistant tooth enamel of mouse consists highly ordered 
micro/nano architecture of hydroxyapatite crystallites that assemble into a woven rod 
structure (SEM image). Each rod is composed of thousands of hydroxyapatite 
particles (inset: cross-sectional image of a mouse incisor; white region is enamel, 
backed by grayish dentine) [7] 
Inorganic-binding biomolecules (proteins, polypeptides, oligonucleotides etc.) could 
potentially be used as biolinkers in the synthesis and assembly of functional 
nanostructures and they could also be the building blocks of self-assembled materials 
with controlled organization and specific functions [1,7]. 
1.2  Obtaining Inorganic Binding Proteins 
There are some traditional techniques which are used to create nano – technologic 
systems, melting and solidification processes, followed by thermo-mechanical 
treatments, or solution/vacuum deposition and growth processes can be exemplary 
for traditional techniques, but these techniques have some difficulties and limitations 
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 like requiring high temperature, pressure and pH adjustment, and usually produce 
toxic byproducts [1-13]. On the other hand, obtaining desired size nano particles can 
be difficult with these methods. However, nature can overcome these limitations and 
produce hybrid materials in mild conditions. As an example ice binding (antifreeze) 
proteins are well characterized in some fish, plant and insect species. These proteins, 
composed of repeating polypeptide units, control ice formation via binding and 
preventing the growth of ice crystals in the internal fluids [13]. TiO2 binding proteins 
were isolated from a Rhodococcus strain, which can adhere to TiO2 layer with its 
nano - bridge shape proteins [14]. Another example is silica binding proteins in 
Cylindrotheca fusiformis (unicellular algae) [15] and Tethya aurantia [16]. 
There are several possible ways to isolate and determine the specific inorganic 
binding proteins. One of the known techniques is to extraction the proteins from 
tissues [6-12]. In this approach extraction of proteins and cloning of their genes are 
complicated and time consuming. Furthermore, the number of  isolated and 
characterized proteins is limited [17]. In addition other biomolecules can affect the 
inorganic biomineralization so this technique becomes much more difficult and 
complex [18,19]. Although this technique is complex some proteins are isolated and 
used in inorganic substrate synthesis and growth [20,21]. In mammalian enamel 
synthesis amelogenin is the utilized protein [18] and in sponge spicula formation 
silicatein is used [17], these can be the best examples of these functional proteins. 
Inorganic binding proteins can be designed with [22] molecular approaches similar to 
those used in pharmaceutical drug research but these require the usage of time 
consuming and expensive methods such as difficult extraction procedures [12,6]. 
1.2.1 Application of Display Technologies in Selection of Inorganic Binding 
Polypeptides 
Since traditional methods of isolation and identification of inorganic binding 
polypeptides have disadvantages, various and faster methods have been developed. 
In these approaches molecular libraries or combinatorial libraries which are 
composed of a random combination of a given number of amino acids display on 
biological systems. Combinatorial biology techniques also have limitations such as 
the requirement of complex polypeptide production and the need of having many 
chemical reactions [12,23,24]. Display technologies can improve these 
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 disadvantages. In this approach phage display (PD) and cell surface display (CSD) in 
vivo techniques are used for selection of inorganic binding polypeptides [25,26]. A 
large, random library of peptides with the same number of amino acids, but of 
different sequence compositions, is screened to identify specific sequences that 
strongly bind to a target inorganic material surface [27,28,29]. These techniques can 
be applied in design of new drugs, enzymes, antibodies, DNA-binding proteins and 
diagnostic agents [26,30]. Nowadays these techniques are also adopted for selection 
of inorganic specific polypeptides. In this method there is no need to have prior 
information about the polypeptides sequences which are specific to the selected 
material.  
Fig. 1.2 represents the procedure for in vivo display techniques [31],  
Step 1Æ Libraries are generated by inserting randomized oligonucleotides within 
certain genes encoded on phage genomes or on bacterial plasmid in PD and CSD. 
Step 2Æ A random polypeptide sequence is incorporated within a protein residing 
on the surface of the organism such as the coat protein of a phage or an outer 
membrane or flagellar protein of a cell.  
Step 3Æ Each phage or cell produces and displays a different, but random peptide.  
Step 4Æ The library which has a heterogeneous mixture of recombinant cells or 
phages is exposed on the inorganic substrate.  
Step 5Æ Non-binder cells or phages are eliminated by several washing cycles by 
disrupting weak interactions with the substrate and the cells or phages.  
Step 6Æ The next step is taking the binders out by eluting them from the surface. 
Step 7Æ In PD, the eluted phages are amplified by reinfecting the host;  
Step 7-8Æ Cells are allowed to grow in CSD which has only one host cell type. 
This is the end of a round of biopanning which is generally repeated for 3-5 times to 
enrich for tight binders.  
Step 9Æ Individual clones are sequenced to get the related amino acid sequences of 
the polypeptides which bind to the target substrate material. 
In CSD, outer membrane proteins, lipoproteins, fimbria and flagellar proteins have 
been used so far for heterologous surface display on bacteria. In PD, most of the 
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 research has been performed using filamentous phages such as M13 or the closely 
related fd and f1. Random peptide libraries have been displayed on bacteriophages 
T7, T4 and λ, but these systems have not used on a routine basis yet. 
 
Fig. 1.2 PD and CSD. Principles of the protocols used for selecting polypeptide 
sequences that have binding affinity to given inorganic substrates [31]. 
1.2.1.1 Phage Display Technique 
Phage display, developed by G. Smith in 1985 [26], is the most efficiently adapted 
molecular display technique [26,32]. Phage display proved to be an effective tool for 
various biological and biotechnological research. Indeed, this technology has been 
used to determine the target sequences for monoclonal antibodies and to identify 
ligands for antibodies in complex polyclonal serums [33]. It relies on the ability of 
certain phage to allow additional peptide sequences to be incorporated into the coat 
proteins without disrupting their structure and function by linking the DNA sequence 
encoding the protein and the peptide itself [34]. Since researches have started on 
inorganic binding polypeptides with combinatorial biology methods gallium arsenide 
[28], silica [35], silver [36], zinc sulfide [37], calcite [38], cadmium sulfide [39], and 
noble metals such as platinum and palladium [40] binding specific polypeptides have 
been identified by phage display technique. 
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 1.2.1.2 M13 filamentous bacteriophage 
M13 is a filamentous bacteriophage uses E. coli as its host. It is approximately 1μm 
in length and 10 nm in diameter [41]. The genetic material of M13 bacteriophage is 
composed of single-stranded circular DNA form (Fig.1.3) [42]. The particle is 
surrounded by a proteinaceous coat. M13 DNA encodes totally 10 proteins, 5 of 
them are related with coat, and the others are related with phage replication and 
assembly [43]. 
 
           Fig. 1.3 M13 genome [42]. 
The coat consists of five different proteins, but the vast majority consists of several 
copies of the major coat protein P8 (~ 2700 subunits) which covers the length of the 
phage. Other four minor coat proteins are represented with 5 copies approximately. 
P3 and P6 proteins form the one end of particle while P7 and P9 proteins form the 
cap of other end [43]. In Fig. 1.4 structure and coat proteins of M13 bacteriophage 
are shown [44]. 
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Fig. 1.4 Structure of M13 bacteriophage and distribution of coat proteins [44]. 
Both major and minor coat proteins contribute to the structural stability of the phage, 
but P3 is needed for host cell recognition and infection also. Besides, P3 is the most 
complicated coat protein and it has three distinct domains. The N-terminal domain 
initiates translocation of the phage DNA into E. coli during infection, while second 
domain recognizes the host cell by binding to the F pilus on the E.coli surface. The 
C-terminal domain attaches with other coat proteins to stabilize P3 protein [43]. 
M13 can only infect bacteria that carry an F or F-like conjugative plasmid that 
encodes the proteins that make up the F pilus. F pili are extracellular filaments found 
on F+ strains of Escherichia coli, where they are involved in the early stage of 
conjugation when cell-cell contacts are formed. The F pili are also the recognition 
sites for infectious bacteriophages, like fd and M13, where the initial recognition, 
mediated by the minor coat protein P3 of the bactariophage, is followed by phage 
DNA translocation into the bacterium. [45]. 
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 The DNA strand present in phage particle is named as the plus or + strand. After 
entry into the cytoplasm of the host cell, the (+) strand DNA is instantly coated with 
an E.coli single stranded DNA binding protein known as SSB. The SSB coating 
protects DNA from degradation [46].  
 
Fig. 1.5 The conversion of the M13 plus strand to a doublestranded DNA molecule. 
The plus strand enters the cell (a and b) with gpIII attached. It is immediately coated 
with host SSB (c). RNA polymerase synthesizes a short primer (d) and DNA 
polymerase synthesizes the minus strand [47]. 
The M13 plus strand is converted to a double-stranded molecule immediately after 
entry into E. coli. Synthesis of the complementary strand is performed by E. coli’s 
DNA synthesis machinery. The complementary strand is called as the minus or (—) 
strand. Minus strand is used as the template for mRNA synthesis and it is the 
template for the translation of the encoded M13 gene products. The SSB proteins fail 
to bind to ~60 nucleotides of the molecule. These nucleotides form a hairpin loop to 
prevent nuclease degradation. M13 gpIII is found associated with the hairpin loop. 
The hairpin loop is recognized by E. coli RNA polymerase as a DNA replication 
origin and is used to initiate transcription of a short RNA primer, in order to create 
the minus strand the RNA primer is extended by E. coli DNA polymerase III. The 
RNA primer is removed by the exonuclease activity of E. coli DNA polymerase I. 
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 The gap is filled in by polymerizing activity of the same DNA polymerase. The final 
phosphodiester bond resulting in a covalently closed double-stranded circular M13 
DNA is formed by E. coli ligase. The double-stranded form of M13 DNA is called as 
the replicative form (RF) DNA. The M13 gene II encoded protein is an endonuclease 
that nicks the plus strand of the RF DNA at a specific place to initiate the replication 
process for M13 RF DNA. Approximately 100 copies of M13 RF DNA are made. 
While the M13 DNA is being replicated, the coat proteins are being synthesized. 
When M13 gpV protein accumulates to sufficient levels, gpV blocks the synthesis of 
the minus strand, probably by displacing SSB on the plus strand and preventing the 
plus strand from being used as a template [48]. The plus strand is circularized. 
1.3 Types of Phage Display Libraries 
Phage display system described in this study is based on simple M13 phage vector 
for display of peptides as N-terminal fusions to the minor coat protein pIII [49]. In 
contrast to libraries of peptides fused to the major coat protein pVIII, which typically 
have on the order of 100 displayed peptides per virion, pIII libraries have a 
maximum valency of only five peptides per virion. As a result of this greatly reduced 
valency, pIII libraries are the best suited to the discovery of higher-affinity ligands. If 
the displayed peptide is sufficiently short (<100 residues), the infectivity function of 
pIII is not adversely affected, and all five copies can carry displayed peptides without 
appreciable attenuation of phage infectivity [50]. Commercial phage display libraries 
mostly contain 7, 12, 15 amino acids insertion. 
1.4 The Substrate: Titanium Powder 
Titanium has been selected as a substrate for this study. The biocompatible metallic 
materials used for manufacturing cement-less arthroprostheses are characterized by 
high fatigue stress and corrosion resistance; their surface finishing is extremely 
important for the bone integration of the implant [51]. It is well known that titanium 
and titanium based alloys exhibit high biocompatibility [52]. However, titanium and 
titanium alloys are still not sufficient for prolonged clinical use because the 
biocompatibility of these materials must be improved [53]. The development of 
surface modification is a real necessity for the biomedical community. Titanium with 
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 a biocompatible coating such as hydroxyapatite has been successfully studied in 
recent years [54].  
1.5 Adapting Phage Display Technology for Selecting Inorganic Binding 
Polypeptides 
Although phage display is a usefull tool for identification of the peptides that take 
roles in protein protein interactions, it can be applied in selecting inorganic binding 
polypeptides. However, some morphological and specificity analyses must be 
performed on inorganic substrate. Density, surface area, average particle size and 
surface morphology are analysed in order to get a detailed information about 
substrate. Following the characterization of material, phage display screening 
procedure is applied to the inorganic material. This procedure based on affinity 
selection with 5 basic steps: Binding, washing, elution, amplification and 
purification. These steps may be called together as biopanning (Fig. 1.6) [55]. 
 
Fig. 1.6. Basic steps of biopanning. a) phage library, random insert in gpIII, b) 
binding of phage to the substrate, c) washing step to get rid of non specific phage, d) 
elution of specific phage, e) amplification of eluted phage, f) purification of 
amplified phage, g) Extraction of phage and DNA sequencing [55]. 
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 1.6 Selection of Phage Library 
The Ph.D.-C7CTM library consists of randomized 7-mer peptides, each flanked by a 
pair of cysteine residues. In the absence of reducing agents, these cysteines 
spontaneously form a disulfide bond, resulting in each peptide in the library being 
constrained in a disulfide loop. The Ph.D.-C7CTM library contains 3.7 x 109 
independent clones. Like the other libraries, the library is fused to pIII via the Gly-
Gly-Gly-Ser spacer (Fig. 1.7). The Ph.D.-C7C library is useful for targets whose 
native ligands are in the context of a surface loop, such as antibodies with structural 
epitopes. Additionally, imposing structural constraint on the unbound ligand results 
in less unfavorable binding entropy, improving the overall free energy of binding 
compared to unstructured ligands. A major disadvantage of the Ph.D.-C7C library is 
that the disulfide constraint may "freeze out" a conformation required for target 
binding [56]. 
 
Fig. 1.7. Differences between constraint and unconstrainted library. 
1.7 Synthetic Biology and Molecular Biomimetics 
Synthetic Biology refers to the design and construction of new biological parts, 
devices and systems, and also re-design of existing, natural biological systems for 
useful purposes by inspiring from nature [1,57]. Molecular biomimetics, biological 
micro electro mechaniacl systems (bioMEMS), physics and bioinformatics can 
gather under the topic of synthetic biology. In this study phage display procedure is 
performed to design novel organic-inorganic hybrids. Molecular biomimetics is 
based on combination of traditional physics and biology applications. Molecular 
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 biomimetics simultaneously offers three solutions to the development of 
heterofunctional nanostructures. The first is designing protein templates at the 
molecular level through genetics. This ensures complete control over the molecular 
structure of the protein template (DNA-based technology). The second is that surface 
specific proteins can be used as linkers and molecular errectors to bind synthetic 
entities, including nanoparticles, functional polymers, or other nanostructures onto 
molecular templates (molecular and nanoscale recognition) (Fig. 1.8).  
 
Fig. 1.8. Schematic illustration of the potential utility of inorganic-binding proteins 
as (a) linkers for nanoparticle immobilization, (b) functional molecules that assemble 
on specific substrates, and (c) heterofunctional linkers involving two (or more) 
binding proteins adjoining several nanoinorganic units. NSL, nonspecific linker [6]. 
Third, some complex nano, and possibly hierarchical structures, similar to those 
found in nature (self-assembly) can be designed by using the self- and co-assemble 
ability of biological molecules to into ordered nanostructures [1]. 
1.8 Aim of the Study 
The aims of the study can be ordered as follow, selecting titanium specific C7C 
polypeptides and investigating their binding strength, identification of the 
polypeptide sequences from good binders which are suitable for biomimetic 
applications, determination of the cross specificity of strong binders with silica, 
silver and platinum, comparing the selected sequences with the sequence identified 
before. At the end, determined sequences may be utilized for nanobiotechnological 
studies.  
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2.MATERIALS AND METHODS  
2.1. MATERIALS 
2.1.1. Bacterial Strain- E. coli ER2738 Host Strain 
E.coli ER2738 , F´ lacIq Δ(lacZ)M15 proA+B+ zzf::Tn10(TetR)/fhuA2 supE thi 
Δ(lac-proAB) Δ(hsdMS-mcrB) was used during the experiments. It is not a 
competent strain and it was purchased as 50 % glycerol culture within Ph.D.-C7C™ 
Phage Display Peptide Library Kit, (2003). 
 
Figure 2.1. Image of a single E.coli ER2738 cell with 24,000X magnification and 2 s. 
exposure time. 2% Ammonium Molybdate solution was used for staining. Bar is 1μm. 
2.1.2. Phage Display Peptide Library-Peptide C7C Phage Display Library 
(Ph.D.-C7C™) 
Phage display peptide library is provided in a 100 µl, with 1.5 x 1013 pfu/ml. It is 
supplied in TBS with 50% glycerol. It has complexity of ~ 2.7 x 109. The library was 
purchased within Ph.D.-C7C™ Phage Display Peptide Library Kit, Catalog 
#E8120S.  
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2.1.3. Inorganic Targets: Titanium Powder 
Titanium powder (Istanbul Technical University - Istanbul) was used as the substrate 
for the biopanning steps. Our SEM analyses of the powder show the size and 
morphology of the substrate. 
                                 
                    Fig. 2.2. Images of Titanium powder magnified at 5.0 kV x 200        
 
Fig. 2.3. Image of Titanium powder with detailed magnification at 5.0 kV x1000 
2.1.4. Bacterial Culture Media 
2.1.4.1. Luria Bertani (LB) Medium 
10 g tryptone (Acumedia Neogen Corporation USA/Canada), 5 g yeast extract 
(Acumedia Neogen Corporation USA/Canada) and 5 g NaCl (Riedel-de-Haen Seelze 
Germany) were dissolved in distilled water and completed up to 1 lt and the pH was 
adjusted to 7.0-7.5 with 10 M NaOH and sterilized for 15 min. under 1.5 atm at 121 
˚C. The medium was stored at room temperature. 
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2.1.4.2. LB Agar Medium 
10 g tryptone (Acumedia Neogen Corporation USA/Canada), 5 g yeast extract 
(Acumedia Neogen Corporation USA/Canada), 5g NaCl (Riedel-de-Haen Seelze 
Germany) and 15 g bactoagar (Acumedia Neogen Corporation USA/Canada) were 
dissolved in distilled water and completed up to 1 lt and the pH was adjusted to 7.0-
7.5 with 10 M NaOH and sterilized for 15 minutes under 1.5 atm at 121˚C. After 
autoclaving, tetracycline solution (Sigma Chemicals USA) (final concentration of 10 
μg/ml) and X-gal/IPTG solution (final concentration of 40 μg/ml) (Fermentas/Sigma 
Chemicals USA) were added when the temperature of the medium was cooled down 
to 45-50 ºC. The medium was shaken properly and poured into the plates by 
avoiding any bubble formation (3.5 ml for small plates and 10 ml for big plates). 
After the medium was solidified in the plates, they were turned upside down and 
stored at 4 ˚C for later use. 
2.1.4.3. Top-Agar Medium 
10 g tryptone (Acumedia Neogen Corporation USA/Canada), 5 g yeast extract 
(Acumedia Neogen Corporation USA/Canada), 5 g NaCl (Riedel-de-Haen), 1 g 
MgCl2 (Riedel-de-Haen Seelze Germany), 9 g LMP (Low Melting Point) agarose 
(Acumedia Neogen Corporation USA/Canada) were dissolved in distilled water and 
completed up to 1 lt and sterilized for 15 minutes under 1.5 atm at 121 ˚C. The 
medium was stored at room temperature and melted in microvawe as needed to pour 
onto the LB agar plates.  
2.1.4.4. E. coli Overnight Culture 
5 ml LB solution containing 1 mM MgCl2 and tetracycline, was inoculated with E. 
coli ER-2738 stock (from -80°C). The culture was left in the shaker overnight at 
37°C, 200 rpm.  
2.1.5. Stock Solutions 
2.1.5.1. Tetracycline-HCl Stock 
20 mg/ml tetracycline-HCl (Sigma Chemicals USA) was dissolved in 95% ethanol. It 
was covered with aluminium foil to protect from sunlight and then stored at -20°C. 
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2.1.5.2. Xgal/ IPTG Stock 
1.25 g IPTG (isopropyl β-D-thiogalactoside) (Sigma Chemicals USA) and 1 g Xgal 
(5-Bromo-4-chloro-3 indolyl-β-D-galactoside) (Fermentas Chemicals) were 
dissolved in 25 ml Dimethyl formamide (Riedel-de-Haen Seelze Germany). Solution 
was stored at –20°C at dark to protect from the light. 
2.1.5.3. Detergent Stock  
20 % (w/v) Tween 20 (Riedel-de-Haen Seelze Germany) and 20 % (w/v) Tween 80 
(Merck Corporation USA) were mixed and distilled water was added up to 20 ml.  
2.1.5.4. Glycerol Stock Solution   
80 ml of 100% glycerol (Sigma Chemicals USA) was mixed with distilled water up 
to 100 ml total volume to have 80 % glycerol solution. It was sterilized for 15 
minutes under 1.5 atm at 121˚C and then stored at room temperature.  
2.1.5.5. MgCl2 Stock Solution 
1M  MgCl2.6H2O (Fisher Chemicals UK) was dissolved in distilled water and 
completed up to 100 ml. and sterilized with 0.2 μm single use syringe filter. 
2.1.5.6. Gelatin Solution  
10mM Tris-HCl pH 8.02, 150 mM NaCl, 0.05% Tween20 and 1% Gelatin dissolved 
in distilled water and completed up to 100 ml and sterilized with 0.2 μm single use 
syringe filter.         
2.1.6 Buffer Solutions 
2.1.6.1 PEG/NaCl 
20% (w/v) polyethylene glycol-8000 (Sigma Chemicals USA), 2.5 M NaCl (Sigma 
Chemicals USA) were dissolved in distilled water and completed up to 100ml and 
sterilized for 15 min. under 1.5 atm at 121˚C. The solution was stored at room 
temperature.  
2.1.6.2. PC (Potassium Phosphate-Sodium Carbonate Buffer) 
• PC (no detergent): 55 mM KH2PO4 (Fisher Chemicals UK), 45 mM Na2CO3 
(Fisher Chemicals UK), 200 mM NaCl (Sigma Chemicals USA) were dissolved in 
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distilled water and completed up to 500 ml and the solution was sterilized by using 
0.2 μm single use syringe filter. The pH value was adjusted to 7.2-7.5.                       
• PC (containing 0.02% detergent): 55 mM KH2PO4 (Fisher Chemicals UK), 
45 mM Na2CO3 (Fisher Chemicals UK), 200 mM NaCl (Sigma Chemicals USA), 0.5 
ml detergent stock solution were dissolved in distilled water and completed up to 500 
ml and the solution was sterilized by using 0.2 μm single use syringe filter. The pH 
value was adjusted to 7.2-7.5.   
• PC (containing 0.1% detergent): 55 mM KH2PO4 (Fisher Chemicals UK), 
45 mM Na2CO3 (Fisher Chemicals UK), 200 mM NaCl (Sigma Chemicals USA), 2.5 
ml detergent stock solution were dissolved in distilled water and completed up to 500 
ml. and the solution was sterilized by using 0.2 μm single use syringe filter. The pH 
value was adjusted to 7.2-7.5.   
• PC (containing 0.5% detergent): 55 mM KH2PO4 (Fisher Chemicals UK), 
45 mM Na2CO3 (Fisher Chemicals UK), 200 mM NaCl (Sigma Chemicals USA), 
12.5 ml detergent stock solution were dissolved in distilled water and completed up 
to 500 ml. and the solution was sterilized by using 0.2 μm single use syringe filter. 
The pH value was adjusted to 7.2-7.5.  
Note: PC buffer can not be sterilized with autoclave because carbonate ions are 
converted to C02 due to high pressure. This causes an increase in pH up to 10. PC 
buffer is sterilized with 0.2 μm syringe filters. 
2.1.6.3. Elution Buffers  
• Elution buffer I: 0.2 M glycine (Merck Corporaiton USA) and 1mg /ml BSA 
(Sigma Chemicals USA) were dissolved in distilled water and completed up to 50 
ml. and pH was adjusted to 2.2 with 10 M HCl and 0,1 M HCl. The solution was 
sterilized by using 0.2 μm single use syringe filter. 
• Elution buffer II: Equal amount of elution buffer A and B are mixed and the 
solution is sterilized by using 0.2 μm single use sterile syringe filter. 
• Elution buffer A:  0.2 M glycine (Merck Corporation USA) and 2 mg /ml 
BSA (Sigma Chemicals USA), 0.02% SDS were dissolved in distilled water and 
completed up to 50 ml. and the pH adjusted to 2.2 with 10 M HCl and 0.1 M HCl. 
The solution was sterilized by using 0.2 μm single use syringe filter. 
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• Elution buffer B: 1 M NaCl (Riedel-de-Haen Seelze Germany), 100 mM 
DDT (Sigma Chemicals USA), 7 mM TCEP (Sigma Chemicals USA), 100 mM ME 
were dissolved in distilled water and completed up to 50 ml.  
2.1.6.4. Tris Buffer 
5% casein (Sigma Chemicals USA), 10 mM Tris-base (Merck Corporation USA), 
150 mM NaCl, 1% Tween 20 (Riedel-de-Haen Seelze Germany) were dissolved in 
0.1 M NaOH. The pH was adjusted to 8.2 and distilled water was added up to 50 ml. 
2.1.6.5. TBE (Tris / Borate / EDTA) Solution 
10X TBE buffer was prepared by dissolving 108 g tris-base (Merck Corporation 
USA), 55 g boric acid (Riedel-de-Haen Seelze Germany) and 4 % (v/v) 0.5M EDTA 
(Merck Corporation USA) at pH 8.0. Distilled water was added to complete up to 1 
lt. 
2.1.7. Agarose Gel Electrophoresis 
Agarose gels (1%) were made by dissolving 1 g agarose (Sigma Chemicals USA) in 
TBE and electrophoresed as described by Sambrook, J. [62]. 10X TBE buffer was 
prepared by dissolving 108 g tris-base, 55 g boric acid (Riedel-de-Haen Seelze 
Germany.) and 4 % (v/v) 0.5 M EDTA (Merck Corporation USA) at pH 8.0. 
Distilled water was added to complete up to 1 lt. 
2.1.7.1. DNA Molecular Weight Markers 
Lambda DNA/EcoRI+HindIII Marker 3 (MBI Fermentas, #SM0193) is used to 
determine the presence of single stranded 7222 base paired M13 DNA.  Marker 3 can 
be used to discriminate 21226, 5148, 4973, 4268, 3530, 2027, 1904, 1584, 1375, 947, 
831, 564, 125 base paired DNAs. 
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Fig. 2.4. Lambda DNA/EcoRI+HindIII Marker 3 (MBI Fermentas, #SM0193) 1.0% 
agarose, 0.5μg/lane, 8cm length gel, 1X TAE, 17V/cm. 
2.1.7. Lab Equipments 
Autoclaves                                         : 2540 ML benchtop autoclave, Systec GmbH                
Labor-Systemtechnik. 
                                                            : NuveOT 4060 vertical steam sterilizer, Nuve. 
Balances                                             : Precisa BJ 610C, order# 160-9423- 050,  
Precisa Instruments AG Dietikon. 
                                                 : Precisa XB 220 A, order# 320-9204-001,               
Precisa Instruments AG, Dietikon. 
Centrifuges                                         : Avanti J-30I, Beckman Coulter. 
                                                             : Microfuge 18, Beckman Coulter. 
 
Centrifuge rotors                               : JA30.50Ti, Beckman Coulter. 
                                                             : F241.5P, Beckman Coulter. 
Deep freezes and refrigerators        : Heto Polar Bear 4410 ultra freezer, JOUAN 
                                                               Nordic A/S, catalog# 003431. 
                                                             : 2021 D deep freezer, Arcelik. 25 
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Deep freezes and refrigerators          : 1061 M refrigerator, Arcelik. 
Electrophoresis equipments              : E-C Mini Cell Primo EC320, E-C Apparatus. 
: Mini-PROTEAN 3 Cell and Single-Row                      
AnyGel Stand, Catalog# 165-3321, Bio-Rad. 
                                                              : Mini-V 8·10 Vertical Gel Electrophoresis 
                                                              System, Life Technologies GibcoBrl (now 
                                                              Invitrogen), Catalog# 21078. 
Gel documentation system                 : UVIpro GAS7000, UVItec Limited. 
Glassware                                            : Technische Glaswerke Ilmenau GmbH. 
Ice Machine                                         : AF 10, Scotsman. 
Incubators                                            : EN400, Nuve. 
Orbital shaker                                     : Certomat S II, product# 886 252 4, B. Braun 
                                                                Biotech International GmbH. 
Magnetic stirrer                                  : AGE 10.0164, VELP Scientifica srl. 
                                                               : ARE 10.0162, VELP Scientifica srl. 
Microscope                                            : BX60, Olympus Corporation. 
                                                                : CH60, Olympus Corporation. 
Microscope Camera                             : RT Slider, Spot Diagnostic Instruments, 
Laminar Flow Cabinet                         : Ozge. 
Pipettes                                                  : Pipetteman P10, P 100, P1000, Eppendorf 
pH meter                                                : MP 220, Mettler Toledo International Inc. 
                                                                : Inolab pH level 1, order# 1A10-1113, 
                                                                  Wissenschaftlich-Technische Werkstätten 
                                                                  GmbH & Co KG. 
Power supply                                          : EC 250-90, E-C Apparatus. 
Pure water systems                                : USF Elga UHQ-PS-MK3, Elga Labwater. 
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Spectrophotometer                                : DU530 Life Science UV/ Vis, Beckman.26 
                                                                 : UV-1601, Shimadzu Corporation. 
Ultrasonic bath                                      : Transsonic TP 690,elma® 
Sterilizer                                                 : FN 500, Nuve. 
Transilluminator                                   : UV Transilluminator 2000, Catalog# 170- 
                                                                   8110EDU, Bio- Rad. 
Vacum Dryer                                          : DNA Mini, JOUAN Nordic. 
Vacuum Pump                                        : Vacuum Station, Catalog# 165-5004, Bio-                        
Rad. 
Vortexing machine                                 : Reax Top, product# 541-10000,   
Heidolph2.2. 
2.2 METHODS 
2.2.1. Phage Display Protocol 
Phage display technique is based on incubating phage library (Ph.D.C7C™) with 
target substrate, and washing away the unbounded phage, and eluting the bound 
phage. Then the eluted phage was amplified by host strain ER2738. After 
amplification, phages were purified. Aim of these steps is to enrich the binding 
sequences pool. After 3 rounds, DNA sequencing was performed for the analysis of 
each individual clones. 
2.2.2. Screening Procedure 
As shown in the optimized screening procedure for selecting specific inorganic-
binding polypeptides is given basically in (Figure 2.5.b). Biopanning is carried out 
by incubating a library of phage-displayed peptides with target, washing away the 
unbound phage, and eluting the specifically-bound phages. The eluted phage is then 
amplified and taken through additional binding/amplification cycles to enrich the 
pool in favor of binding sequences. After 3 rounds of biopanning, individual clones 
are selected and sequenced. 
The screening protocol is given in the figure 2.5.b and follows as described here;  
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1) PhD-C7C library (New England Biolabs, MA) of M13 phage each displaying a 
different peptide sequence was used as the randomized peptide source.  
2) Titanium powder was used as the substrate and cleaned prior to the biopanning 
rounds in the phage display screening method to select the titanium specific 7 amino 
acid polypeptides.  
 
a) 
 
                                                                                                                                                                 
 
b) 
           Figure 2.5. a) Structure of M13 phage and b) Phage display procedure 
3) The phage library interacted with the surface of the substrate in potassium 
phosphate- sodium carbonate buffer (pH 7.5) containing 0.1% detergent solution 
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(20% Tween80 + 20% Tergitol). The detergent in the buffer was used to reduce the 
phage-phage interactions and by this way, the phages were expected to expose with 
the titanium surface individually.  
4) Unbound phages were washed away by several washing steps using PC buffer (pH 
7.5) containing 0.1% detergent solution. Washing cycles were repeated ten times, 
each one taking 30 min. The detergent concentration was increased gradually up to 
0.5% as the number of the rounds is going up towards to 3.  
5) Specifically bound phage was eluted from the surface with strong buffer solutions  
containing glycine-HCl (pH 2.2), 1 mg/ml bovine serum albumine (BSA), 0.02% 
sodium dodecyl sulphate (SDS), 1 M sodium chloride (NaCl), 100 mM dichloro-
diphenyl-trichloroethane (DDT), 7 mM tris (chloroethyl) phosphate (TCEP) and 100 
mM mercaptoethanol (ME). After 15 min treatment with the elution buffer, the 
eluted phages were transferred to a fresh tube and neutralized with tris-HCl (pH 9.1)  
6) The eluted phage pool was amplified with Eschericia coli ER2738 host cell which 
is a robust F+ strain with a rapid growth rate and particularly well-suited for M13 
propagation. ER2738 is a recA+ strain and the F-factor of ER2738 contains a mini-
transposon which confers tetracycline resistance. The amplified phages were then 
plated on Luria Bertani (LB) plates containing 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (Xgal) and isopropyl-β-D-1-thiogalactosidase (IPTG).  
7-9) Single plaques were picked and ssDNA isolated from these plates were 
sequenced. This is one round of biopanning. For the second round of panning, the 
eluted phage after the first round was used as the pool. After each round, the 
complexity of the pool decreases.  
2.2.3. Biopanning Steps  
2.2.3.1. Cleaning of the Titanium Powder 
• In order to avoid the clump formation cleaning procedure was performed against 
titanium powder. 
• ~ 3 gr titanium powder was sonicated for 15 min in absolute EtOH. 
• The EtOH was discarded and distilled water was added into the substrate to 
sonicate the powder for another 15 min. 
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• After discarding distilled water from the eppendorf tube, PC buffer was added 
into the tube and the powder waited in the PC buffer containing 0.1% detergent 
overnight for the surface stabilization. 
• After overnight, the titanium powder was taken into fresh PC buffer containing 
0.1% detergent which was now ready to add library for biopanning rounds.  
2.2.3.2. Washing Steps  
• 20 mg of titanium powder was put into microfuge tube and 1 ml PC buffer 
containing 0.1 % detergent was added into the tube.  
• 10 µl of phage display peptide library (Ph.D.-C7C™) was added into microfuge 
tube and placed on the running cylinder for 30 min rotation.  
• After 30 min rotation, the supernatant was discarded and transferred into 
microfuge tube which was prelabelled as XTiRxS1*.  
• Titanium powder was washed for 2 min with 1 ml PC containing 0.1 % 
detergent. 
• The washing steps were repeated 6 times. 
• The supernatants which were discarded at the end of the each washing steps were 
transferred into microfuge tubes which were prelabelled as XTiRxW1**, XTiRxW2, 
XTiRxW3, XTiRxW4, XTiRxW5, and XTiRxW6. 
• After taking the supernatant out, microfuge tube containing titanium and phage 
peptide library was put on the running cylinder for 30 min rotation.  
• The supernatant was discarded and transferred into microfuge tube XTiRxW7. 
• 1 ml PC buffer containing 0.1 % detergent was added onto the tube and rotated 
for 30 min. 
• The supernatant was discarded and transferred into microfuge tube XTiRxW8. 
• Another 1 ml PC buffer containing 0.1 % detergent solution was added into the 
tube and left on rotation for overnight. 
• Following overnight rotation, supernatant was discarded and transferred into 
microfuge tube XTiRxW9. 
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• 1 ml PC buffer containing % 0.1 detergent solution was added into the tube and 
rotated for 30 min on running cylinder. 
• The supernatant was discarded and transferred into microfuge tube XTiRxW10.  
• 1 ml PC buffer containing % 0.1 detergent solution was added into the tube and 
rotated for 30 min on running cylinder. 
• The supernatant was discarded and transferred into microfuge tube XTiRxW11. 
*: XTiRxS1: XÆ Number of screening, TiÆ Titanium, RxÆRound number (here it 
is 1), S1ÆSupernatant Sample 1. 
**: XTiRxW1: XÆNumber of screening, TiÆ Titanium, RxÆRound number (here 
it is 1), W1ÆWashing Sample 1. 
The washing steps were performed to remove the non-specific phage to titanium 
surface. At the end of the all washing steps, phage which bound to titanium surface 
must be eluted from the surface. The elution steps come just after the washing steps 
and follow as written below. One round of biopanning contains washing, elution and 
purification steps. Basically all elution and purification steps are the same in each 
round but washing steps change as the number of the rounds increases. The detergent 
concentration in the washing buffers is increased gradually from 0.1% to 0.5% up to 
3rd round. 
2.2.3.3. Elution Steps 
Following the washing steps, elution of the good binders from the surface of the 
titanium powder comes next. During the elution step, the eluted phages must be 
inoculated with the host bacteria for starting the amplification steps. Therefore, E. 
coli ER2738 liquid culture was needed for phage–host strain infection and 
amplification of phage prior to inoculating the phages with the host bacteria, we 
needed to have LB solution containing host bacteria of E. coli ER2738, growth of 
which reached OD600 value of 0.5. One night before starting the elution steps, 5 ml 
LB solution containing 10 μl 1M MgCI2 (1:500), 5 μl tetracycline (1:1000) was 
incubated with a single colony which was withdrawn from the glycerol culture of the 
bacteria and inoculated LB waited overnight at 37ºC and 200 rpm. In the day of 
elution, 125 μl (1:400) E. coli ER2738 overnight culture was used to inoculate a 
fresh 50 ml LB solution containing 100 μl 1M MgCI2 (1:500), 50 μl tetracycline 
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(1:1000) in 250 ml glass medium flask. 5 different 50 ml LB in 250 ml shake flasks 
were prepared for the elution steps. They were incubated until mid-log phase (OD600 
~ 0.5) at 37ºC and 200 rpm. 
• After the last washing step, 1 ml of elution Buffer I was added onto the titanium 
powder in a clean microfuge tube and rotated for 15 min on running cylinder to elute 
the phage from titanium powder. 
• The supernatant was transferred into microfuge tube XTiRxE1*. 
• 800 μl supernatant was transferred into E. coli ER2738 culture (OD600 ~ 0.5) and 
incubated for 4.5 hours at 37ºC and 200 rpm. 
• The remaining 200 μl supernatant was neutralized by adding 40 μl of tris, pH 9.1 
• 1 ml of Elution buffer II was put into microfuge tube containing the titanium 
powder and put on the running cylinder for 15 min to elute the phage from titanium 
surface.  
• The supernatant was discarded and transferred into microfuge tube XTiRxE2. 
• 800 μl of the supernatant was transferred into E. coli ER2738 culture (OD600 ~ 
0.5) and incubated for 4.5 hours at 37ºC and 200 rpm.  
• The remaining 200 μl supernatant was neutralized by adding 40 μl of tris, pH 9.1 
• 1 ml of Elution buffer II was put for the second time into microfuge tube. 
• Microfuge tube which contained titanium powder and elution buffer II was put 
on the running cylinder for 15 min to elute the phage from titanium surface. 
• The supernatant was transferred into microfuge tube XTiRxE3. 
• 800 μl supernatant from XTiRxE3 was transferred into E. coli ER2738 culture 
(OD600 ~ 0.5) and incubated for 4.5 hours at 37ºC and 200 rpm.  
• The remaining 200 μl supernatant was neutralized by adding 40μl of tris, pH 9.1 
• 1 ml of Elution buffer II was put, for the third time, into microfuge tube. 
• Microfuge tube containing titanium and elution buffer II was put on the running 
cylinder for 15 min to elute the phage from titanium surface  
• The supernatant was transferred into microfuge tube XQRE3. 
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• 800 μl supernatant from XTiRxE3 was transferred into E. coli ER2738 culture 
(OD600 ~ 0.5) and incubated for 4.5 hours at 37ºC and 200 rpm 
• The remaining 200 μl supernatant was neutralized by adding 40μl of tris, pH 9.1 
• As a last step of the elution process, titanium powder itself was put into the LB 
solution containing E. coli ER2738 culture (OD600 ~ 0.5) and incubated for 4.5 hours 
at 37ºC and 200 rpm 
*: XTiRxE1: XÆ Number of screening, TiÆ Titanium, RxÆ Round number (here it 
is 1), E1Æ Elution Step 1. 
2.2.3.4. Purification Steps 
After the elution steps, the eluted phages needs to be amplified and then the 
amplified phages must be isolated. The purification process of the amplified phages 
follows as written below. 
• At the end of 4.5 hours of growth period, E. coli - phage culture (in 50 ml LB) 
was transferred into 250 ml sterilized centrifuge tubes.  
• Samples were centrifuged at 8,000 rpm for 10 min. 
• Supernatants were transferred into 250 ml sterilized centrifuge tubes. 
• 8.33 ml (1:6) of PEG / NaCl solution was added into supernatant to precipitate 
phage and it was left for overnight at 4 0C. 
• After overnight, samples were centrifuged clockwise (CW) and counter 
clockwise (CCW) at 8,000 rpm for 10 min. 
• Supernatants were discarded and phage pellet was resuspended with 5 ml PC   
buffer (no detergent) by shaking to remove any remaining E. coli. 
• Samples were centrifuged CW and CCW at 8,000 rpm for 10 min. 
• Supernatant was transferred into 50 ml sterilized centrifuge tubes. 
• 0.833 ml of PEG / NaCl (1:6) was added into the solution to precipitate phage 
and the solution was left for 2 hours at 4 0C. 
• Samples were centrifuged CW and CCW at 10,000 rpm for 10 min. 
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• Supernatants were discarded and phage pellets were resuspended by pipetting or 
shaking with 1 ml PC buffer (no detergent) to remove E-coli. 
• Samples were centrifuged CW and CCW at 10,000 rpm for 10 min and 
supernatants were transferred into sterilized microfuge tubes. 
• 0.166 ml of PEG / NaCl solution (1:6) was added into the microfuge tube to 
precipitate phage, sample was vortexed for 5 sec, and left for 10 min at RT. 
•  Samples were centrifuged CW and CCW at 13,500 rpm for 1.5 min to get the 
compact phage. 
• Supernatant was discarded and phage pellet was resuspended with 0.2 ml PC 
buffer (no detergent) by pipetting gently. 
• Samples were centrifuged at 13,500 rpm for 1.5 min. 
• Supernatant were transferred into sterilized microfuge tubes and stored at 40C. 
At the end of the purification step, blue-white screening experiment was done.  
2.2.4. Titers of the Selected Phages 
2.2.4.1. Blue-white Screening Experiments 
At the end of each biopanning round, blue-white screening experiment was carried 
out to determine the phage titers. Basically, amplified phages were grown in the 
plates which had Xgal, IPTG and tetracycline. 50 μl Xgal/IPTG from 20 mg/ml 
stock, 100 μl 1M MgCl2 (1:500), 50 μl tetracycline (1:1000) were put into 50 ml 
liquid warm LB agar in 100 ml glass medium flask and it was poured into plastic 
sterile petri dishes. Plates were  wrapped with parafilm and stored at 40C at dark for a 
maximum of 1 month. Purified phages needed to be serially diluted to estimate phage 
titers.            
2.2.4.2. Preparation of Diluted Phage and Plating 
190 μl PC buffer (no detergent) was put into the first well in Elisa plate. 180 μl PC 
buffer (no detergent) was put into other wells to dilute the sample as in Figure 2.6. 10 
μl phage stock solution was put in the first well having 10-1 dilution. Phage and PC 
buffer were mixed by pipetting. 20 μl sample was taken from the first well and put 
into the second well to have totally 200 μl of solution mix having 10-2 dilution level 
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of the phages. The remaining serial dilutions were done the same way as it is labeled 
in Figure 2.5.  
One night before plating, overnight culture was prepared to be used in the day of the 
plating. 5 ml LB solution containing 10 μl 1M MgCI2 (1:500), 5 μl tetracycline 
(1:1000) was incubated with 12.5 μl E. coli ER2738 from overnight culture in 50 ml 
falcon tube. It was incubated until mid- log phase (OD600 ~ 0.5) at 37ºC and 200 rpm. 
Xgal/IPTG-tet plates were taken out from 4oC refrigerator and put at RT and labeled. 
Previously melted top agar was placed in the water bath at ~ 50 oC to prevent 
solidification of the top agar till adding the diluted phage solutions.  
 
                                  Fig. 2.6. Making the serial dilutions on the Elisa plate 
20 μl diluted phage solution was mixed with 180 μl LB solution containing E. coli 
cells with OD600 ~ 0.5 resulting one more dilution of the phages. The resulting 
solution was mixed with warm LB agar (0.5 ml for small Petri dishes and 3.5 ml for 
big Petri dishes) in 15 ml falcon tubes and vortexed. The phage and bacteria mixture 
solution were poured onto the plates and waited for 5-10 min for the solidification of 
the top agar. All petri dishes were inverted and incubated at 37oC for 8-14 hours. 
After incubation period blue plaques were seen visually on the plate as in Figure 2.7. 
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 Fig. 2.7. Shows the individual colonies at the end of incubation in blue-white 
screening 
2.2.4.3. Phage Titers for Each Round 
At the end of the each round, phage titer was estimated by doing blue-white 
screening experiment. Amount of phage after each elution steps determines the 
amount of the phage which will be used from that elution step to form gene pool for 
the next round. Table 2.1 shows the titers after amplification of the phages from each 
elution steps, and the amount of the phage from that step to use forming the gene 
pool for the next round. 
Table 2.1. Phage titers and amount of phage used for the next round after each round. 
(D: Dilution number, A: Amount of phage solution used for the phage pool for the 
next round as microliter) 
 1st Round 2nd Round 3rd Round 
Elution D A D A D A 
A1 10-12 100 10-12 100 10-13 100 
A2 10-12 50 10-12 50 10-15 50 
A3 10-14 50 10-12 50 10-9 50 
A4 10-13 50 10-15 50 10-11 50 
B 10-15 50 10-17 50 10-13 50 
2.2.4.4. Saving Clones for Sequencing  
After estimation of titers by plating on small plates, eluted phages from each round 
were plated on the big plates to pick plaques to be saved for sequencing. 
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2.2.4.5. Preparation of Storage Plates  
•  200 μl PC buffer containing 0.02 % detergent solution was put into each well of 
a sterile 96-well Elisa plate. 
• At the end of the fifth round, 600 individual plaques have been picked. 
• Elisa plate containing phage clones was placed into the incubator at 60 0C for 45 
min. 
2.2.4.6. Preparation of Glycerol Stock of Phage  
• 60 μl sterilized 80% glycerol solution was put into each well of a fresh 96-well 
plate. Two sets of 96 well Elisa plate have been prepared, one for -20 ºC and one for 
-80 ºC stocks. (Overall glycerol concentration was kept as ∼ % 50 in stocks.) 
• 50 μl clone from the storage plate was added into the glycerol containing plates. 
• Plates were covered by parafilm and placed into the freezers, -20 and–80 oC. 
2.2.5. Single Stranded DNA Isolation  
2.2.5.1. M13 Single Strand DNA Isolation 
For the sequencing of the individual sequences, ssDNAs of the picked sequences 
needs to be isolated. QIAprep ® Spin M13 kit (QIAGEN, Catolog #27704) was used 
for the isolation of M13 phages which were previously stored at -20 ºC stock. The 
procedure is given schematically in Figure 2.8 and written below. 
1) 50 μl from each individual sample which belongs to only one phage plaque was 
taken from the glycerol stock and added into 2 ml E. coli ER2738 culture which had 
been incubated until mid-log phase (OD 600 ~0.5) in 2 ml microfuge tubes. Phage and 
bacteria mixture was incubated for 4.5 hours for E. coli ER2738 infection by phage 
and amplification.  
2) Culture containing microfuge tubes were centrifuged at 5000 rpm for 15 min at 
room temperature. Supernatant containing M13 bacteriophage was transferred into a 
fresh reaction tube. During transferring the supernatant, bacterial pellet was not 
disturbed. Any carryover of bacterial cells result in contamination of the M13 
precipitation with bacterial chromosomal DNA or double-stranded bacteriophage RF 
DNA. 
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3) Buffer MP was added 1/100 volume (i.e.10μl per 1 ml of phage supernatant.) onto 
the supernatant in the reaction tube. It was mixed by vortexing and incubated at room 
temperature for at least 2 min. During this step, bacteriophage particles were 
precipitated from the culture medium. 
4) A QIAprep spin column was placed in a 2 ml microcentrifuge tube and 0.7 ml of 
the sample was applied to the QIAprep spin column. 
5) Reaction tube was centrifuged for 15 s. at 8,000 rpm and discarded flow-through 
from collection tube. Here, intact bacteriophage was retained on the QIA prep silica-
gel membrane.  
6) The last step was repeated until all supernatant passed through QIAprep spin 
column. 
7) 0.7 ml MLB buffer was added for M13 lysis and binding, to the QIAprep spin 
column and centrifuged for 15 s at 8,000 rpm. This step creates appropriate 
conditions for binding of the M13 DNA to the QIAprep silica-gel membrane. 
Bacteriophage lysis begins. 
 32
 
Figure 2.8.  M13 ssDNA isolation procedure (QIAGEN, Catolog #27704). 
8) Another 0.7 ml MLB buffer was added into the QIAprep spin column and 
incubated for 1 min at room temperature to lyse the bacteriophage completely. 
QIAprep spin column was centrifuged for 15 s at 8,000 rpm. M13 single-stranded 
DNA was released from bacteriophage particles and adsorbed to the QIAprep to the 
silica gel membrane. 
9) 0.7 ml Buffer PE was added into the QIAprep column and centrifuged for 15 s at 
8,000 rpm to remove the residual salt. 
10) Buffer PE was discarded from collection tube and QIAprep spin column was 
centrifuged for 15 s at 8,000 rpm to remove residual buffer PE. It is important not to 
dry the QIAprep membrane quick microcentrifugation step. This prevents residual 
ethanol from being carried over into subsequent reactions. QIAprep spin column was 
placed in a clean 1.5 ml microcentrifuge tube. 100 μl EB buffer (10 mM tris.Cl, pH 
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8.5) was added onto the center of the column membrane to elute the DNA. 
Incubation of elution buffer in the QIAprep spin column significantly increases the 
recovery of single-stranded M13 DNA molecules, which adsorb tightly to the silica 
membrane. 
11) After 10 min of waiting at RT, the tube is centrifuged for 30 sec at 8,000 rpm to 
collect the isolated ssDNA samples in the tube. 
2.2.5.2. Measurement of DNA concentration by spectrophotometry 
Each 2 or 4 μl DNA sample was diluted with 998 or 996 μl dH2O (1:500, 1:250). The 
samples were put into the quartz cuvette. The absorbance of DNA was measured at 
260 nm and at 280 nm to quantify the amount of DNA. The purity of DNA samples 
was determined by calculating the ratio of absorbent at 260/280 nm. 
2.2.6. Sequencing of DNA Sample 
2.2.6.1. PCR Conditions for DNA Sequencing 
PCR reactions were done for the total volume of 10 µl in the 0.2 ml PCR reaction 
tubes. 
Table 2.2. PCR conditions for DNA sequencing. 
PCR ingredients Amount 
Big dye reaction mix* 1µl 
5X sequencing buffer / dH2O 2 µl 
Template ssDNA 2 µl (150 ng) 
Primer (-96 sequencing primer) 
** 
3.2 µl (3.2 
pmol) 
dH2O   1.8 µl 
Total volume  10 µl 
*Big dye ® terminator v3.1 cycle sequencing Kit from Applied Biosystems for the 
amplification of ssDNAs. 
** –96 gIII sequencing primer (5´- CCC TCA TAG TTA GCG TAA CG –3´, 100 
pmol, 1 pmol/μl) was purchased from New England Biolabs Ph.D.-C7C™ Phage 
Display Peptide Library Kit 
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PCR conditions for cycle sequencing was; 
95 ºC  2’                                          
95 ºC  10’’ 
55                    10’’ 
60  4’ 
35 cycle 
2.2.6.2. PCR Product Purification  
•  2 μl, (3M pH 4.6 sodium acetate) and 50 μl, 95 % ethanol were mixed for 
each sample. 
 • 52 μl mixture was put into each PCR product and all samples were put on 
dry ice for 30 min. 
• All samples were centrifuged for 30 min. at 14000 rpm. 
• Supernatant was discarded from each sample and 250 μl cold ethanol was put 
into each sample. 
• All samples were centrifuged for 30 min. at 14000 rpm. 
• Ethanol was discarded from each sample and 20 μl hi-di formamide was put 
into each sample. 
• Samples were put first 95oC and then -20oC for 5 min. to denature the 
samples. 
DNA samples were sequenced by using an ABI 3100 Avant (PE, Applied Biosystem, 
CA) automated sequencer. 
2.2.7. Immunofluorescence Microscopy Experiments  
2.2.7.1. Cleaning of the Titanium Powder  
• Around 100 mg of titanium powder was weighted and put into pre-weighted 1.5 
ml microfuge tube. 
• 100 μl dH2O and 900 μl CH3OH/acetone (1:1) mixture were added into the tube. 
The powder was dissolved gently by pipetting. 
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• The sample was vortexed for 5-10 min to observe the forming clumps and then 
sonicated for 20 min in an ultrasonic bath to break the clumps. 
• The powder was vortexed quickly to resuspend and centrifuged at 200 g for 1.5 
min (CW and CCW). 
• The supernatant was removed and 1 ml 50 % isopropanol was added onto the 
powder. 
• Powder was vortexed for 5-10 min and then sonicated for 20 min in the 
ultrasonic bath. 
• The powder was vortexed quickly to resuspend and spinned down at 200 g for 3 
min (CW and CCW). 
• The supernatant was removed and 1 ml 0.5 % PC buffer was added onto the 
powder. 
• The powder was first vortexed for 5-10 min and then sonicated for 60 min. 
• The powder was vortexed quickly to resuspend. 
• The powder was centrifuged at 200 g for 1.5 min (CW and CCW). 
• The supernatant was removed and 1ml 0.5 % PC buffer was added onto the 
titanium powder. 
• 100 μl of powder solution was transferred into each sterile microfuge tube. 
• Powder was spinned down at 200 g for 1.5 min. 
• Powder was first washed twice with dH2O and then with isopropanol. 
• Samples were dried under the vacuum. 
• All samples were weighted to determine the amount of powder into the each 
tube. 
2.2.7.2. Fluorescence Microscopy Experiment Procedure  
Following the sequencing results, each phage clone was checked for binding and 
specificity on titanium. The binding of the phage samples on the titanium suface can 
be observed visually under the fluorescence microscopy indirectly. Zenon complex 
(Zenon Alexa, Molecular Probes Inc) which has labeled Fab fragment bound on IgG 
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is used to label the phages for indirect observation. The procedure is basically as 
follows; 
• A proper amount of previously cleaned titanium powder was incubated with 5 μl  
phage (PFU/ml 1013) in PC buffer containing 0.1 % detergent and rotated overnight.  
• After attaching phage to the powder, this conjugate was incubated with tris buffer 
containing gelatine blocking agent for 10 min, in order to coat the powder and 
occupy any binding sites that antibody might attach to.  
• Each phage sample was labeled according to the immunolabelling procedure as 
in Figure 2.9. First, Anti-M13 pIII monoclonal antibody (Amersham Biosciences) 
which is specific to m13 gp8 protein and Alexa-Fluor conjugated secondary antibody 
fragments (Zenon Alexa, Molecular Probes Inc.) that contains flourescence dye were 
incubated (1: 5 ratio) for  30 min in a microfuge tube covered by aluminium foil.  
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                            Overnight incubating phages with Titanium powder  
 
 
                        +           
              Unlabeled IgG       Zenon labeling reagent      Incubation              Labeled fab 
                 Antibody            (labeled fab fragments)                                       fragments 
 
 
               
   Labeled Fab IgG complex bound pIII protein of the phage 
Figure 2.9. Labeling procedure for fluorescence microscopy (not scaled).  
• While Zenon mixture was being prepared, phage-titanium powder solution was 
centrifuged at 1,000 rpm for 1.5 min, the supernatant was discarded and 0.1 % PC 
buffer was added on the sample for 15 min rotation on running cylinder to wash 
unbound phage out of the solution.  
• The solution was centrifuged again at 1,000 rpm for 1.5 min and the supernatant 
was discarded.  
• 3 μl Zenon dye complex and 497 μl PC buffer containing no detergent were put 
on the phage–titanium solution and incubated for 30 min on running cylinder to let 
phage- mixture interaction. The tube was covered with aluminium foil.  
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• The solution was centrifuged again at 1,000 rpm for 1.5 min and the supernatant 
was discarded. 
• 0.5 ml 0.1 % PC buffer was added into the tube and the powder was washed 3 
times by pipetting. 
• The mixture solution was centrifuged again at 1,000 rpm for 1.5 min and the 
supernatant was discarded. 
• Another 0.5 ml 0.1 % PC buffer was added into the tube and the powder was 
washed 3 times by pipetting. 
• The mixture solution was centrifuged again at 1,000 rpm for 1.5 min and the 
supernatant was discarded. 
• 30 μl 0 % PC buffer was added onto the powder solution and visualized by 
fluorescence microscopy (BX60 Olympus Corporation) at 20X magnification under 
WIB filter.  
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                    3. RESULTS AND DISCUSSION 
3.1 Identification of the Binder Peptides for Titanium and Their Sequence 
Based Analysis 
This study focuses on selection of disulfide-constrained heptapeptides exhibiting 
affinity towards titanium powder surface using phage display technique. Amorphous 
titanium powder was used as a substrate for the selection of titanium-specific 7 
amino acid polypeptides from C7C phage display library. During the selection of 
titanium binders by phage display technique, different buffer solutions with different 
pH ranges were used. These buffers can cause oxide layer formation on the surface 
therefore material characterization studies were performed in order to obtain 
information about particle morphology and average particle size. 
Following material characterization, screening was carried out to select titanium 
binding polypeptides. During screening 3 rounds of biopanning experiments were 
carried out. In biopanning steps, washing buffer strength gradually increased due to 
the round numbers to select better binders after each round. During the washing 
steps, non-specific binders were removed from the titanium powder surface. After 
the washing steps, chemical elution cycles were performed with low pH buffers to 
remove the specific phage bound onto the material. Bound phage recovery approach 
was also applied after elution steps to recover the phage remained on the material. 
Phage colonies were selected to isolate the ssDNA from both chemical elution and 
recovered bound phage. After biopanning, 10, 21 and 20 sequences were studied 
from first, second and third rounds respectively. As a result of 3 rounds of 
biopanning, 51 sequences were identified as the titanium binding polypeptides. 
In the next step sequence characterization was performed. Characterization studies 
could be divided into three different categories. Physicochemical properties of 
selected polypeptides  were analyzed and compared with respect to their pI, MW, 
and charge in first characterization category. In the second categorization section 
statistical amino acid analyses of each selected sequences were carried out. Analyses 
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were based on calculation of overall amino acids distributions. The amino acid 
distributions of selected polypeptides were compared with the observed frequency of 
amino acids in the commercial phage library we used. Expression levels of observed 
amino acids were analyzed by comparing the observed sequences in the library and a 
relative abundance graph was prepared to observe the low or high expression levels 
of each amino acids. Last step of characterization employed semi-quantitative 
fluorescence microscopy studies. Sequences were analyzed by means of their 
affinities towards titanium. Individual phage colonies with determined DNA 
sequences were incubated with titanium powder, then the phage were labeled with 
monoclonal antibody IgG and Alexa Fluor secondary antibody fragment. This 
approach was the best and easiest way of categorize the sequences by their affinities 
to titanium. Depending on fluorescence microscopy results, binders were grouped as 
strong, moderate and weak binders. The sequences that bind to titanium with an 
affinity of 0%-10% were classified as “weak binders”, those that bind to titanium 
with an affinity of 10%-40% were classified as “moderate binders” and those that 
bind to titanium with an affinity of 40%-100% were called “strong binders”. Affinity 
percantages were calculated by software programme Image Pro Plus. 
Selection of the titanium binding polypeptides did not grant us with the information 
about the specificity of these polypeptides for titanium metal and not for the others. 
In order to determine the level of specificity of these peptides for titanium, cross 
specificity fluorescence microscopy experiments were performed on platinum, silver 
and silica. Cross specificity experiments were perrformed with platinium, silver and 
silica. After cross specificity studies, strong and specific titanium binding 
polypeptides were determined. 
3.1.2 Characterization of Titanium Powder 
Characterization studies can be grouped into 4 types: Surface area studies, density 
measurements, particle size measurements, morphology observations. 
3.1.2.1 Surface Area Calculation Results 
Surface area was measured by Nova Station B (Quantachrome Instruments) as 13.78 
m2/g. 
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                   3.1.2.2 Density Measurement Results 
3 runs were performed to measure density. 
Table 3.1. Utilized volume of titanium and density for each rounds. 
Run Volume (cc) Density (g/cc) 
1 0,1849 4,3426 
2 0,1869 4,2967 
3 0,1931 4,1578 
After performing 3 runs with titanium powder, average density measurement was 
found 4.2643 g/cc. 
3.1.2.3 Particle Size Results 
Particle size was measured by Hydro 2000 G(A) (Malvern Instruments, UK) 
Table 3.2.  Particle size distribution of titanium powder. 
 
It was found that titanium powder contains different size of particles between 10μm-
220μm. Average size of powder was calculated as 103μm. 
3.1.2.4 Surface Morphology Analyses Results 
Titanium Powder Morphology observation was performed at 2 magnification scale  
with JEOL JSM T-330 Scanning Electron Microscope (SEM) (JEOL, Japan). 
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Fig 3.1. SEM image, magnification of titanium powder at 200X.                                  
 
Fig 3.2. SEM image of titanium powder magnification at 1000 X.  
3.2 Screening Results  
3 rounds were performed to obtain titanium specific polypeptides in screening. 
Bound phage recovery was also studied at each round. Among a total of 51 
sequences, 18 were from bound phage recovery. Physicochemical properties of each 
polypeptide were also calculated; isoelectric point (pI) and molecular weight (MW) 
were calculated by pI/MW computing tool [58]. The charges of the polypeptides 
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were calculated by subtracting the number of basic residues (R and K) from the 
number of acidic residues (D and E). 
Table 3.3. 7 amino acids polypeptide sequences obtained from 3 rounds. 
Amplification # Sequence Isoelectric point MW Charge 
1st Round A1  S T T Q H S L 6,46 772 0 
1st Round A2  D I S P P S H 5,08 752 -1 
1st Round A2  N S S A L Q L 5,52 731 0 
1st Round A3 N M A L S Q G 5,52 720 0 
1st Round A3 P N V R T E A 6,43 785 -2 
1st Round A3 N D K K D L L 5,96 844 0 
1st Round A4 T P L L N T D 4,3 772 -1 
1st Round Bound H S L D S F N 5,08 818 -1 
1st Round Bound N T H A N H H 7,02 829 0 
1st Round Bound I D G D Q R S 4,21 789 -1 
2nd Round A2 L H D T R S H 6,92 864 0 
2nd Round A2 S T A Y P L N 5,24 764 0 
2nd Round A2 A P A Q H K V 8,8 749 0 
2nd Round A2 S V E E R G S 4,53 762 -1 
2nd Round A2 N T A T L P S 5,52 702 0 
2nd Round A3 I H Q D S H A 5,97 806 -1 
2nd Round A3 P T A D S N M 3,8 735 -1 
2nd Round A3 Q H G M T R Q 9,76 856 1 
2nd Round A3 A P T A G L P 5,57 625 0 
2nd Round A3 P L N D Q Y F 3,8 895 -1 
2nd Round A4 P V T I H S S 7,17 739 0 
2nd Round A4 A E Q L R P P 6,05 809 0 
2nd Round A4 A Q V N T Y D 4,3 809 0 
2nd Round A4 S T Q D P K P 5,55 771 0 
2nd Round A4 R D P Q T F T 5,84 863 0 
2nd Round Bound T S R S E T M 5,66 810 0 
2nd Round Bound M P T S T L P 5,28 745 0 
2nd Round Bound P W S F Q T P 5,96 861 0 
 44
2nd Round Bound P G T T N L N 5,96 715 0 
2nd Round Bound H D R H T P L 6,92 874 0 
2nd Round Bound R D Q T P A Y 5,84 849 0 
3rd Round A1 H Q A H T S Q 6,92 807 0 
3rd Round A1 L T R S S S H 9,76 787 1 
3rd Round A1 H G Y S N S Q 6,74 791 0 
3rd Round A2 M S Y V K P G 8,34 780 1 
3rd Round A2 K A P L N S M 8,75 759 1 
3rd Round A3 H S H N L H N 7 858 0 
3rd Round A3 S G A P S A L 5,24 601 0 
3rd Round A3 D L E N N R M 4,37 890 -1 
3rd Round A4 H G N L H A T 6,92 749 0 
3rd Round A4 K T T P Y A H 8,6 816 1 
3rd Round A4 M G N K T P K 10 774 2 
3rd Round Bound L P H N N P Q 6,74 819 0 
3rd Round Bound P M S P H A L 7,17 752 0 
3rd Round Bound P G P Q Q M T 5,96 758 0 
3rd Round Bound N R Q D L P H 6,74 879 0 
3rd Round Bound F E V G P L H 5,24 797 -1 
3rd Round Bound A P L P N A S 5,57 668 0 
3rd Round Bound S T V S P N T 5,24 704 0 
3rd Round Bound S N S P V S S 5,24 676 0 
3rd Round Bound D L M T T H P 5,08 813 -1 
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Table 3.4. Shows the amino acid distribution. Blue bars show the amino acids 
percentage observed in sequences while yellow bars show amino acids percentage 
observed in library. 
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After selecting the sequences, D, H, N, Q  were observed as overexpressed amino 
acids. D carries an acidic group on its side chain while H, N, Q carry amine and basic 
groups. In sequence base, there is no trend of convergence to a specific sequence or 
any accumulation in a specific round. Moreover, it is not possible to tell which 
sequence has high affinity or which one is more specific. 
3.3 Immunofluorescence Microscopy Experiment Results 
So far, all the sequences were evaluated with respect to sequence and statistical 
analyses. Lack of a consensus sequence formation makes necessary to have further 
analysis therefore each sequence was analyzed individually using fluorescence 
microscopy. At the beginning of the examination with fluorescence microscopy, 
control experiments were also carried out. Control experiments did not contain the 
phage but only contained the fluorescence dye mixture. Following the control 
experiment, fluorescence microscopy experiments were performed on all samples 
using the procedure described earlier. 
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Fig 3.3. Shows control experiment images of fluorescence microscopy. 
 
Fig 3.4. Shows R D P Q T F T sequence with binding affinity percentage 88% (a 
strong binder). 
 
Fig 3.5. Shows L H D T R S H sequence with binding affinity percentage 28%(a 
moderate binder). 
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 Fig 3.6. Shows A Q V N T Y D sequence with binding affinity percentage 0% (a 
weak binder). 
Fluorescence and optical microscopy images of samples from 3 groups; strong, 
moderate and weak binders. 
Table 3.5. Groups of selected polypeptides by their affinities to titanium after 
fluorescence microscopy studies; listed as strong, moderate and weak binders. 
       Round Name
MW 
(DA) Charge pI % Type 
              
R D P Q T F T 2 / A4  SK1 863 0 5,84 88 S 
R D Q T P A Y 2 / B SK2 849 0 5,84 81 S 
S T V S P N T 3 / B SK3 704 0 5,24 74 S 
S T T Q H S L 1 / A1 SK4 772 0 6,46 63 S 
S T Q D P K P 2 / A4 SK5 771 0 5,55 58 S 
L P H N N P Q 3 / B SK6 819 0 6,74 52 S 
P Q P Q Q M T 3 / B SK7 758 0 5,96 51 S 
H S H N L H N 3 / A3 SK8 858 0 7 46 S 
S N S P V S S 3 / B SK9 676 0 5,24 43 S 
L H D T R S H 2 / A2 SK10 864 0 6,92 38 M 
H S L D S F N 1 / B SK11 818 -1 5,08 37 M 
H D R H T P L 2 / B SK12 874 0 6,92 37 M 
H G N L H A T 3 / A4 SK13 749 0 6,92 36 M 
K T T P Y A H 3 / A4 SK14 816 1 8,6 34 M 
P M S P H A L 3 / B SK15 752 0 7,17 31 M 
P V T I H S S 2 / A4 SK16 739 0 7,17 29 M 
M P T S T L P 2 / B SK17 745 0 5,28 29 M 
A P L P N A S 3 / B SK18 668 0 5,57 29 M 
P G T T N L N 2 / B SK19 715 0 5,96 23 M 
P N V R T E A 1 / A3 SK20 785 -2 6,43 20 M 
S T A Y P L N 2 / A2 SK21 764 0 5,24 18 M 
H G Y S N S Q 3 / A1 SK22 791 0 6,74 18 M 
M S Y V K P Q 3 / A2 SK23 780 1 8,34 16 M 
L T R S S S H 3 / A1 SK24 787 1 9,76 15 M 
A P A Q H K V 2 / A2 SK25 749 0 8,8 15 M 
Q H G M T R Q 2 / A3 SK26 856 1 9,76 13 M 
P W S F Q T P 2 / B SK27 861 0 5,96 12 M 
D I S P P S H 1 / A2 SK28 752 -1 5,08 10 W 
A P T A G L P 2 / A3 SK29 625 0 5,57 8 W 
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K A P L N S M 3 / A2 SK30 759 1 8,75 8 W 
S G A P S A L 3 / A3 SK31 601 0 5,24 7 W 
D L E N N R M 3 / A3 SK32 890 -1 4,37 7 W 
N T H A N H H 1 / B SK33 829 0 7,02 7 W 
T S R S E T M 2 / B SK34 810 0 5,66 7 W 
H Q A H T S Q 3 / A1 SK35 807 0 6,92 7 W 
F E V G P L H 3 / B SK36 797 -1 5,24 5 W 
D L M T T H P 3 / B SK37 813 -1 5,08 5 W 
P T A D S N M 2 / A3 SK38 735 -1 3,8 3 W 
N S S A L Q L 1 / A2 SK39 731 0 5,52 3 W 
N M A L S Q G 1 / A3 SK40 720 0 5,52 3 W 
A E Q L R P P 2 / A4 SK41 809 0 6,05 0 W 
A Q V N T Y D 2 / A4 SK42 809 -1 4,3 0 W 
I D G D Q R S 1 / B SK43 789 -1 4,21 0 W 
S V E E R G S 2 / A2 SK44 762 -1 4,53 0 W 
P L N D Q Y F 2 / A3 SK45 895 -1 3,8 0 W 
N D K K D L L 1 / A3 SK46 785 0 6,43 0 W 
T P L L N T D 1 / A4 SK47 772 -1 4,3 0 W 
M G N K T P K 3 / A4 SK48 774 2 10 0 W 
N R Q D L P H 3 / B SK49 879 0 6,74 0 W 
N T A T L P S 2 / A2 SK50 702 0 5,52 0 W 
I H Q D S H A 2 / A3 SK51 806 -1 5,97 0 W 
At the end of characterization experiments we observed strong binder polypeptides 
were not only from last round but also from early rounds but predominantly from last 
round. Although moderate and weak binders had positive or negative charges, strong 
binders had no charge; yet, all the strong binders had neutral charge. Moreover 
strong binding polypeptides carry some motifs like RD or ST and these motifs were 
thought to be important in binding to the substrate. For more statistical analyses, 
percent relative abundance of amino acids of strong binding polypeptides was 
compared against that of the full library. 
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Figure 3.7. Shows relative abundance between amino acids at strong binding 
polypeptides and amino acids in the library. 
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Relative abundance graph points out that all polar amino acids and some aromatic 
amino acids were overexpressed when compared with library. Another important 
result was the overexpression of aspartic acid and underexpression of glutamic acid 
although both of them were acidic amino acids. 
After comparison of strong binding polypeptides with library, strong binding 
polpeptides were compared with weak binding polypeptides to reveal the relative 
abundance of amino acids. 
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Figure 3.8. Shows relative abundance between amino acids at strong binding 
polypeptides and amino acids in weak binding polypeptides. 
At relative abundance graph between strong binder polypeptides and weak binder 
polypeptides, nonpolar and acidic amino acids show wide range differences. In weak 
binders nonpolar amino acids were overexpressed while underexpressed in strong 
binder. Meanwhile aspartic acid was overexpressed in both strong and weak binders 
but glutamic acid was underexpressed in strong binders while overexpressed in weak 
binders. 
The results shown in the figures above provides sequences of strong, moderate and 
weak binding polypeptides selected in biopanning experiments, yet the specificity of 
the selected polypeptide sequences is still unknown. In order to determine the unique 
titanium binding specificity of the selected strong binders we have to carry out cross 
specificity experiments by fluorescence microscopy with different materials.   
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3.4 Cross Specificity Experiments 
Titanium binding peptides were selected and classified as strong, moderate and weak 
binders. Although binding affinities were known, there was no information about 
their actual specificity for the titanium substrate. In order to determine the specific 
binding peptides, cross specificity experiments were performed with different 
materials with strong titanium-binding polypeptides. In this step platinum, silver and 
silica were used to understand the binding capability of the titanium-binding 
polypeptides against other materials. 
 
Fig 3.9. Cross specificity experiment image of R D P Q T F T (SK1) with platinum 
powder. 
 
Fig 3.10. Cross specificity experiment image of R D P Q T F T (SK1) with silver. 
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 Fig 3.11. Cross specificity experiment image of R D P Q T F T (SK1) with silica. 
 
Fig 3.12. Cross specificity experiment image of L P H N N P Q (SK6) with 
platinum powder. 
 
Fig 3.13. Cross specificity experiment image of  L P H N N P Q (SK6) with silver. 
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 Fig 3.14. Cross specificity experiment image of  L P H N N P Q (SK6) with silica. 
3.5 Statistical Results of Specification Analyses  
At the end of cross specification experiments, strong binding and titanium specific 
polypeptides were selected. R D P Q T F T (SK1) showed the highest affinity to 
titanium and showed no affinity to platinum, silver and silica while some other 
strong binders showed low affinities. 
Strong binding polypeptides exhibited high level expression of polar and aromatic 
amino acids. Strong binding polypeptides carry mostly aspartic acid as an acidic 
amino acid, however low level expression of glutamic acid was observed. Non polar 
amino acids were observed as low expressed amino acids in strong binding 
polypeptides when compared with library frequencies. 
Weak binding polypeptides sequences were mostly rich in non polar amino acids and 
glutamic acids in contrast with the strong binding polypeptides sequences. 
 
 
 
 
 
 
 
 
 53
 4.CONCLUSION 
Titanium binding polypeptides were selected by phage display technique. Before 
screening procedure, material characterization experiments were applied to get 
information about particle size, surface morphology and density. After screening 
experiments 9 strong binder polypeptides were obtained by observing their affinities 
with fluorescence microscopy. At the end of screening procedure, strong binders 
were obtained from all rounds but predominantly from last round, pI of all selected 
polypeptides were calculated and shown that all strong binders were neutral charged, 
RD and ST motifs were observed in strong binder polypeptides 2 and 3 times 
respectively, relative abundance of the amino acids of strong binding polypeptides 
against the frequency demonstrated that strong binders carry mostly polar amino 
acids and aspartic acid, non polar amino acids and glutamic acid were over expressed 
in weak binders, cross specification studies showed that most strong binders had no 
affinities for platinum, silver and silica. 
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APPENDIX 
 
Further informations about amino acids distribution observed in C7C Phage Display 
LibraryTM. (Table A.1) 
 
 
Table A.1 Shows the expected and observed amino acid distributions [56]. 
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Color coding of amino acids were represented Table A.2 
 
Table A.2 Shows the amino acids categorization by their basic properties. 
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